1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Iverson, H.A.
Fox, D.
Nadler, L.S.
Klevit, R.E.
Nathanson, N.M.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
280
24568
24575
10.1074/jbc.M501264200
15870063
Identification and structural determination of the M3 muscarinic acetylcholine receptor basolateral sorting signal.
2005
10.2210/pdb2csa/pdb
pdb_00002csa
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
1995.024
Muscarinic acetylcholine receptor M3
THIRD INTRACELLULAR LOOP (Residues:271-289)
1
syn
polymer
no
no
SGTEAETENFVHPTGSSRS
SGTEAETENFVHPTGSSRS
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2005-05-31
1
1
2008-04-30
1
2
2011-07-13
1
3
2022-03-09
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
RCSB
Y
RCSB
2005-05-21
REL
REL
The peptide was chemically synthesized. The sequence of the peptide is naturally found in Homo sapiens (human).
sample
NOESY spectra were collected with a mixing time of 300ms
structures with the lowest energy
200
10
2D TOCSY
2D TOCSY
2D NOESY
2D NOESY
2D NOESY
2D NOESY
2D NOESY
2D NOESY
DQF-COSY
6.4
ambient
285
K
6.4
ambient
278
K
6.4
ambient
288
K
6.4
ambient
298
K
6.4
ambient
308
K
6.4
ambient
318
K
Structures are based on a total of 58 inter-residue NOE distance restraints and 5 dihedral angle restraints
Distance Geometry, Simulated Annealing, Energy minimization
1
lowest energy
1-2mM M3 peptide, unlabeled, 50mM sodium phosphate buffer, 1mM EDTA, 1mM NaN3, 90% H2O, 10% D20
90% H2O, 10% D20
1-2mM M3 peptide, unlabeled, 50mM sodium phosphate buffer, 1mM EDTA, 1mM NaN3, 99.9 % D20, 0.1% H20
99.9 % D20, 0.1% H20
Bruker
collection
XwinNMR
2.6
Delaglio
processing
NMRPipe
Delaglio
data analysis
NMRView
5
Brunger
refinement
CNS
1.1
500
Bruker
DMX
SER
1
n
1
SER
1
A
GLY
2
n
2
GLY
2
A
THR
3
n
3
THR
3
A
GLU
4
n
4
GLU
4
A
ALA
5
n
5
ALA
5
A
GLU
6
n
6
GLU
6
A
THR
7
n
7
THR
7
A
GLU
8
n
8
GLU
8
A
ASN
9
n
9
ASN
9
A
PHE
10
n
10
PHE
10
A
VAL
11
n
11
VAL
11
A
HIS
12
n
12
HIS
12
A
PRO
13
n
13
PRO
13
A
THR
14
n
14
THR
14
A
GLY
15
n
15
GLY
15
A
SER
16
n
16
SER
16
A
SER
17
n
17
SER
17
A
ARG
18
n
18
ARG
18
A
SER
19
n
19
SER
19
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
THR
3
63.73
129.30
1
A
GLU
4
-149.99
-47.13
1
A
ALA
5
-59.31
-167.18
1
A
THR
7
-172.52
-41.92
1
A
ASN
9
-173.60
100.38
1
A
PHE
10
-147.88
-52.23
1
A
VAL
11
-151.06
-46.89
1
A
SER
17
-60.38
-74.54
1
A
ARG
18
-108.99
-69.92
2
A
GLU
4
-160.57
-51.86
2
A
ALA
5
-84.68
-78.70
2
A
GLU
6
-90.09
52.51
2
A
THR
7
-161.19
81.76
2
A
ASN
9
60.50
100.43
2
A
PHE
10
-152.41
-52.10
2
A
VAL
11
-150.93
-46.91
3
A
GLU
4
-149.98
-47.18
3
A
ALA
5
-59.99
-70.14
3
A
GLU
6
-86.18
-77.32
3
A
THR
7
60.57
92.25
3
A
PHE
10
-127.89
-53.22
3
A
VAL
11
-152.03
-46.69
3
A
THR
14
-57.71
-178.12
4
A
THR
3
60.58
110.66
4
A
GLU
4
-159.93
31.59
4
A
THR
7
-168.96
80.09
4
A
PHE
10
-129.88
-51.51
4
A
VAL
11
-153.62
-45.28
4
A
SER
17
-176.40
-170.09
5
A
THR
3
60.43
87.98
5
A
GLU
4
-152.24
31.67
5
A
ASN
9
-179.18
86.44
5
A
PHE
10
-135.04
-57.81
5
A
VAL
11
-155.50
-45.71
5
A
ARG
18
-166.98
105.09
6
A
THR
3
-163.77
95.05
6
A
GLU
4
-150.52
31.76
6
A
ALA
5
-89.67
-79.36
6
A
THR
7
60.52
97.96
6
A
PHE
10
-95.45
-85.43
6
A
VAL
11
-155.89
-68.56
6
A
SER
16
-171.39
35.45
7
A
THR
3
56.95
104.96
7
A
THR
7
-158.34
84.44
7
A
ASN
9
60.54
80.63
7
A
PHE
10
-73.92
-85.19
7
A
VAL
11
-154.28
-53.37
7
A
HIS
12
178.35
-52.06
7
A
THR
14
-54.54
179.37
7
A
SER
16
-170.03
124.71
7
A
ARG
18
60.51
89.58
8
A
THR
3
68.35
-68.99
8
A
GLU
4
-176.51
-67.44
8
A
ASN
9
-170.23
99.40
8
A
PHE
10
-109.82
-85.58
8
A
VAL
11
-155.88
-69.42
8
A
SER
17
-65.17
95.06
9
A
PHE
10
-121.62
-54.60
9
A
VAL
11
-152.71
-58.42
9
A
ARG
18
60.65
157.96
10
A
THR
3
-105.50
-72.35
10
A
GLU
4
-179.93
130.36
10
A
GLU
6
-90.10
51.50
10
A
ASN
9
-176.80
99.91
10
A
PHE
10
-107.38
-70.52
10
A
VAL
11
-178.28
-78.61
10
A
SER
17
-159.25
31.62
Structure of the M3 Muscarinic Acetylcholine Receptor Basolateral Sorting Signal
1
N
N
Signaling Protein/MEMBRANE PROTEIN
BASOLATERAL SORTING-SIGNAL BLSS BETA-TURN, Signaling Protein-MEMBRANE PROTEIN COMPLEX
ACM3_HUMAN
UNP
1
271
P20309
SGTEAETENFVHPTGSSRS
271
289
2CSA
1
19
P20309
A
1
1
19